Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)
HKD 1.66
(3.75%)
HKD 1.66
(3.75%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -23.59 Million CNY | 2.71% |
| 2022 | -24.25 Million CNY | -52.07% |
| 2021 | -15.94 Million CNY | -64.23% |
| 2020 | -9.71 Million CNY | -11.23% |
| 2019 | -8.73 Million HKD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | - HKD | 100.0% |
| 2024 Q2 | - HKD | 0.0% |
| 2023 Q2 | -14.08 Million HKD | 0.0% |
| 2023 FY | -23.59 Million CNY | 2.71% |
| 2023 Q4 | -9.61 Million HKD | 0.0% |
| 2023 Q3 | - HKD | 100.0% |
| 2023 Q1 | - HKD | 100.0% |
| 2022 Q2 | -11.27 Million HKD | 0.0% |
| 2022 FY | -24.25 Million CNY | -52.07% |
| 2022 Q4 | -12.92 Million HKD | 0.0% |
| 2022 Q3 | - HKD | 100.0% |
| 2021 Q4 | -7.31 Million HKD | 0.0% |
| 2021 Q2 | -8.63 Million HKD | 0.0% |
| 2021 FY | -15.94 Million CNY | -64.23% |
| 2020 FY | -9.71 Million CNY | -11.23% |
| 2019 FY | -8.73 Million HKD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 392.81 Million HKD | 106.007% |
| CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 102.49% |